HOW DOES FINGOLIMOD (GILENYA®) FIT IN THE TREATMENT ALGORITHM FOR HIGHLY ACTIVE RELAPSING-REMITTING MULTIPLE SCLEROSIS?

by Franz eFazekas, Ovidiu eBajenaru, Thomas eBerger, Tanja eHojs Fabjan, Alenka eHorvat Ledinek, Gábor eJakab, Samuel eKomoly, Tetiana eKobys, Jörg eKraus, Egon eKurča, Theodore eKyriakides, Lubomír eLisý, Ivan eMilanov, Sergii eMoskovko, Tetyana eNehrych, Panayiotis ePanayiotou, Sasa eSega Jazbec, Larysa eSokolova, Radomir eTalab, Latchezar eTraykov, Peter eTurčáni, Karl eVass, Norbert eVella, Nataliya eVoloshyna, Eva eHavrdova
Published 2013-05-01